以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002603 以岭药业

已收盘 05-09 15:00:00

{"stockData":{"symbol":"002603","market":"SZ","secType":"STK","nameCN":"以岭药业","latestPrice":13.86,"timestamp":1746774231000,"preClose":13.84,"halted":0,"volume":8149477,"delay":0,"changeRate":0.0014,"floatShares":1377000000,"shares":1671000000,"eps":-0.4205,"marketStatus":"已收盘","change":0.02,"latestTime":"05-09 15:00:00","open":13.85,"high":13.98,"low":13.82,"amount":113000000,"amplitude":0.0116,"askPrice":13.86,"askSize":280,"bidPrice":13.85,"bidSize":883,"shortable":0,"etf":0,"ttmEps":-0.4205,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.84,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":15.22,"lowLimit":12.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1670705376,"isCdr":false,"pbRate":2.19,"roa":"--","roe":"3.14%","epsLYR":-0.4337,"committee":-0.058294,"marketValue":23156000000,"turnoverRate":0.0059,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-05-12。","floatMarketCap":19083000000},"requestUrl":"/m/hq/s/002603","defaultTab":"news","newsList":[{"id":"2533694336","title":"以岭药业：创新驱动发展 近六年研发投入超48亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2533694336","media":"长江商报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533694336?lang=zh_cn&edition=full","pubTime":"2025-05-07 07:11","pubTimestamp":1746573115,"startTime":"0","endTime":"0","summary":"近日，以岭药业正式发布了2024年全年财报及2025年第一季度财务报告。财报披露，2024年全年，该公司研发投入超过9亿元，占营业收入比重为13.94%，处于同行业领先水平。财报显示，2019年-2023年期间，以岭药业研发投入持续呈增长态势，分别为5.15亿元、7.37亿元、8.38亿元、8.95亿元、9.35亿元。以此计算，2019年-2024年，以岭药业研发投入累计达到48.28亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507071447a4748d45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507071447a4748d45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0042","002603","561510","BK0097","BK0188","BK0239","562390","BK0046"],"gpt_icon":0},{"id":"2531773658","title":"以岭药业2025Q1业绩亮眼：扣非净利润同比增长11%，研发与现金流双轮驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2531773658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531773658?lang=zh_cn&edition=full","pubTime":"2025-04-30 13:10","pubTimestamp":1745989824,"startTime":"0","endTime":"0","summary":"证券之星注意到，2025年一季度，以岭药业以净利润同比增长7.25%、扣非净利润同比两位数增长的业绩表现，宣告历经8个季度调整后正式重回增长轨道。证券之星注意到，以岭药业2024年全年经营活动产生的现金流量净额达到6.11亿元，同比增加约293%，经营性现金流大幅改善，财务健康状况显著提升。进入2025年，一季度经营性现金流为3.4亿元，并且超过当季净利润3.25亿元，同比增长近2倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025043000024744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","159399"],"gpt_icon":0},{"id":"2531330215","title":"喜报！以岭药业化学原料药“来曲唑”上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2531330215","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531330215?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:26","pubTimestamp":1745889979,"startTime":"0","endTime":"0","summary":"近日，石家庄以岭药业股份有限公司全资孙公司万洋衡水制药有限公司收到国家药品监督管理局下发的《化学原料药上市申请批准通知书》，由衡水万洋提交的“来曲唑”化学原料药上市申请已获批准。其中芳香化酶抑制剂类药物占全球乳腺癌药物市场38%的份额，来曲唑作为一线治疗药物市场需求稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025042900011572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","BK0239","BK0042","BK0046","002603"],"gpt_icon":0},{"id":"2531321593","title":"以岭药业2024年研发投入超9亿元 多项创新成果登上国际期刊","url":"https://stock-news.laohu8.com/highlight/detail?id=2531321593","media":"全景网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531321593?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:22","pubTimestamp":1745889720,"startTime":"0","endTime":"0","summary":"4月28日晚间，以岭药业发布2024年年报。年报显示，以岭药业研发投入超9亿元，占营业收入比例13.94%，远高于行业平均水平。数据显示，2019～2023年，以岭药业研发投入持续增长，总投入接近40亿元。图为根据以岭药业历年年报披露数据绘制长期高研发投入助力企业加速创新药管线布局。随着这些产品的相继上市放量，以岭药业长期增长可期。截至2024年末，以岭药业有效专利884项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909254097494660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909254097494660&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002603","BK0042","BK0046","BK0097","BK0188","562390","BK0239"],"gpt_icon":0},{"id":"2531213941","title":"以岭药业2025年一季度扣非归母净利润3.25亿元，实现双位数增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2531213941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531213941?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:19","pubTimestamp":1745889595,"startTime":"0","endTime":"0","summary":"4月28日消息，以岭药业今晚发布2024年全年财报及2025年第一季度财务报告显示，公司2024年全年收入65.13亿元，亏损7.25亿元，主要是因部分呼吸系统产品近效期冲减收入和存货减值计提所致；2025年第一季度，扣非后归属于母公司的净利润为3.25亿元，同比增长11.23%，实现双位数增长。2025年Q1净利润3.25亿元 盈利能力显著提升2024年年报显示，公司报告期实现营业收入65.13亿元，归属于上市公司股东的净利润-7.25亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025042900011202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603"],"gpt_icon":0},{"id":"2529316873","title":"A股中药板块异动拉升，华森制药、众生药业午后双双涨停，康缘药业、以岭药业、同仁堂、大唐药业等涨幅居前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529316873","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529316873?lang=zh_cn&edition=full","pubTime":"2025-04-22 13:39","pubTimestamp":1745300355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","BK0086","BK0188","399300","BK0028","600085","LU1688375341.USD","BK0113","002603","BK0012","BK0239","BK0097","002317","BK0077","002907","600557","BK0046","BK0196","BK0183","BK0042"],"gpt_icon":0},{"id":"2528652793","title":"以岭药业荣登2024胡润品牌榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2528652793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528652793?lang=zh_cn&edition=full","pubTime":"2025-04-17 17:26","pubTimestamp":1744882001,"startTime":"0","endTime":"0","summary":"胡润研究院于4月16日正式发布《2024胡润品牌榜》，评选出中国300强最具价值品牌。其中，以岭药业凭借其卓越的品牌影响力和市场表现，成功跻身“地区最具价值品牌前三名”，并荣登医疗健康品牌价值TOP10，再次彰显了其在医药健康行业的领军地位。以岭药业在科技创新领域的成就尤为突出，荣获6项国家科技大奖，其中“中医脉络学说构建及其指导微血管病变防治”荣获2019年度国家科技进步一等奖，这是年度生命科学领域唯一一项一等奖。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025041700026600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","002603","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2527711496","title":"2025乌镇健康大会｜以岭药业斩获多项殊荣，以创新打造医药健康产业新引擎","url":"https://stock-news.laohu8.com/highlight/detail?id=2527711496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527711496?lang=zh_cn&edition=full","pubTime":"2025-04-15 18:55","pubTimestamp":1744714522,"startTime":"0","endTime":"0","summary":"4月8日-12日，江南水乡乌镇迎来了医药健康领域的年度盛会——乌镇健康大会。以岭药业凭借在数字化转型、品牌策略、产品定位、市场渠道等多方面的创新成果，在大会上斩获“西湖奖医药制造数字化榜样企业10强”“西湖奖医药零售数字化领军企业20强”“2025乌镇健康大会VIP战略合作企业”等多项殊荣，成为全场焦点。以岭药业以数字化转型为抓手，推动产业链上下游协同升级。在此次大会上，以岭药业旗下多款产品凭借创新优势脱颖而出。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025041500030348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0046","BK0042","002603","BK0188","BK0239"],"gpt_icon":0},{"id":"2518315177","title":"以岭药业从自然之选到循环经济的“绿色密码”","url":"https://stock-news.laohu8.com/highlight/detail?id=2518315177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518315177?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:24","pubTimestamp":1741656264,"startTime":"0","endTime":"0","summary":"近日，记者走进河北一家中药企业，探访其绿色发展的创新生态模式。以岭药业供图绿色动力：花园工厂，科技之美走进这家中药企业，仿佛置身于一座花园之中。以岭药业能源环保部能源管理科副主任黄昌昌表示：“我们新增了沼气处理系统，将污水处理过程中产生的沼气进行脱硫处理后用于锅炉燃烧，每年可回收沼气约19万方，相当于10万方天然气，经济效益显著。”","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2025031100009975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","002603","BK0042","BK0239","BK0046"],"gpt_icon":0},{"id":"2513724213","title":"以岭药业（002603）股东吴瑞质押53万股，占总股本0.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513724213?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:08","pubTimestamp":1740406080,"startTime":"0","endTime":"0","summary":"证券之星消息，以岭药业2月24日公开信息显示，股东吴瑞向广发证券股份有限公司合计质押53.0万股，占总股本0.03%。质押详情见下表：截止本公告日，股东以岭医药科技有限公司已累计质押股份4900.0万股，占其持股总数的9.3%，股东吴相君已累计质押股份1500.0万股，占其持股总数的4.31%，股东吴瑞已累计质押股份899.0万股，占其持股总数的22.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022400033217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","002603","BK0046","BK0188","BK0239","BK0097"],"gpt_icon":0},{"id":"2512411879","title":"摩洛哥代表团参访以岭药业 共商中摩医药合作新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2512411879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512411879?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:25","pubTimestamp":1740043536,"startTime":"0","endTime":"0","summary":"2月19日，摩洛哥王室成员、摩洛哥-中国合作发展协会秘书长穆罕默德·阿里·亚齐迪一行莅临以岭药业参观访问，就中医药文化传承、创新药物研发以及推动中摩医药产业合作等议题进行了深入交流。她表示，摩洛哥是“一带一路”沿线重要国家，以岭药业期待与摩方加强合作，推动中医药在摩洛哥的推广应用。穆罕默德·亚齐迪表示，摩洛哥与中国在医药健康领域合作潜力巨大，希望双方进一步加强交流，探索合作机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025022000028636.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK1515","162414","BK0097","BK0239","BK0188","BK1161","09939","159938","BK0042","002603","BK1574"],"gpt_icon":0},{"id":"2512457040","title":"以岭药业（002603）2月19日主力资金净卖出1338.29万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512457040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512457040?lang=zh_cn&edition=full","pubTime":"2025-02-20 09:26","pubTimestamp":1740014808,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月19日收盘，以岭药业报收于14.22元，上涨0.0%，换手率0.97%，成交量13.36万手，成交额1.89亿元。2月19日的资金流向数据方面，主力资金净流出1338.29万元，占总成交额7.08%，游资资金净流出751.45万元，占总成交额3.98%，散户资金净流入2089.74万元，占总成交额11.06%。近5日资金流向一览见下表：以岭药业融资融券信息显示，融资方面，当日融资买入1306.37万元，融资偿还921.3万元，融资净买入385.07万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000008090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","002603","BK0097","BK0239","BK0188"],"gpt_icon":0},{"id":"2512432587","title":"以岭药业新提交“以岭健康”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2512432587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512432587?lang=zh_cn&edition=full","pubTime":"2025-02-20 05:18","pubTimestamp":1739999903,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日石家庄以岭药业股份有限公司新提交“以岭健康”商标注册申请。商标申请详情如下：今年以来石家庄以岭药业股份有限公司新申请注册商标4件，截止目前公司共持有注册商标1140件，另有238件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022000003377.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","002603","BK0042","BK0046","BK0239"],"gpt_icon":0},{"id":"2511650919","title":"以岭药业创新中药系统干预心血管事件链破解国际“心难题”","url":"https://stock-news.laohu8.com/highlight/detail?id=2511650919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511650919?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:46","pubTimestamp":1739526391,"startTime":"0","endTime":"0","summary":"心血管事件链以高血脂、高血压、高血糖等危险因素为源头，逐步引发血管内皮损伤、动脉粥样硬化，进而可能导致心肌缺血、冠心病、心绞痛、心肌梗死、心律失常，最终引发心力衰竭，威胁生命。截至目前，以岭药业研发生产的通心络、参松养心、芪苈强心等创新中药已进入50多个国家和地区，为全球患者带来了更多来自东方的健康福祉，书写了中医药国际化新篇章。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025021400030357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0239","BK0188","BK0046","BK0097","BK0042"],"gpt_icon":0},{"id":"2509441587","title":"以岭药业：中药化药领域齐开花，1类新药抢攻千亿市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2509441587","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509441587?lang=zh_cn&edition=full","pubTime":"2025-02-05 10:37","pubTimestamp":1738723033,"startTime":"0","endTime":"0","summary":"值得一提的是，2025年以岭药业已有一款创新药获批上市。1月21日晚，以岭药业发布公告称1类中药创新药“芪防鼻通片”获药监局批准上市，该药用于治疗持续性变应性鼻炎，由以岭药业自主研发。据披露，以岭药业计划每年申报一到两个新药品种，持续在多个领域布局创新中药研发，为公司持续高质量发展贡献力量。其中中药新药柴黄利胆胶囊新药注册申请已获正式受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025020500010076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0097","002603","BK0042","BK0188","BK0239"],"gpt_icon":0},{"id":"2506181443","title":"以岭药业（002603）1月24日主力资金净卖出3465.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506181443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506181443?lang=zh_cn&edition=full","pubTime":"2025-01-27 09:21","pubTimestamp":1737940905,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月24日收盘，以岭药业报收于13.74元，下跌2.0%，换手率2.87%，成交量39.51万手，成交额5.36亿元。近5日资金流向一览见下表：以岭药业融资融券信息显示，融资方面，当日融资买入4141.23万元，融资偿还5019.01万元，融资净偿还877.78万元。融券方面，融券卖出1.79万股，融券偿还3000.0股，融券余量37.51万股，融券余额515.39万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012700002754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0097","BK0046","BK0042","BK0239","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746845884484,"stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0508},{"period":"3month","weight":-0.0335},{"period":"6month","weight":-0.2261},{"period":"1year","weight":-0.279},{"period":"ytd","weight":-0.1343}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"石家庄以岭药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"185292人(较上一季度增加1.53%)","perCapita":"7430股","listingDate":"2011-07-28","address":"河北省石家庄市裕华区高新技术产业开发区天山大街238号","registeredCapital":"167070万元","survey":"　　石家庄以岭药业股份有限公司是一家主要致力于专利创新中药的研发、生产和销售。主要产品包括通心络胶囊、参松养心胶囊、连花清瘟胶囊、芪苈强心胶囊等。公司拥有通过GMP认证的胶囊、片剂、颗粒剂、针剂生产线,以及通过欧盟认证的化学药制剂车间。","listedPrice":34.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"以岭药业,002603,以岭药业股票,以岭药业股票老虎,以岭药业股票老虎国际,以岭药业行情,以岭药业股票行情,以岭药业股价,以岭药业股市,以岭药业股票价格,以岭药业股票交易,以岭药业股票购买,以岭药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}